pegaspargase
Sign in to saveAlso known as L-asparagine amidohydrolase, putative L-asparaginase precursor
Pegaspargase, sold under the brand name Oncaspar, is a medication used in the treatment of acute lymphoblastic leukemia (ALL). Often it is used together with anthracycline, vincristine, and corticosteroids (for example prednisone and dexamethasone). Pegaspargase can be administered either via an intravenous infusion or a intramuscular injection.
Key facts
- Drug.Verifiedfields
- changed
- Drug.verifiedrevid
- 458268975
- Drug.image
- Pegaspargasa.png
- Drug.tradename
- Oncaspar
- Drug.MedlinePlus
- a695031
- Drug.DailyMedID
- Pegaspargase
- Drug.pregnancy_AU
- D
- Drug.routes_of_administration
- Intramuscular, intravenous
- Drug.ATC_prefix
- L01
- Drug.ATC_suffix
- XX24
- Drug.legal_AU
- S4
- Drug.legal_CA
- Rx-only
- Drug.legal_US
- Rx-only
- Drug.legal_EU
- Rx-only
- Drug.CAS_number
- 130167-69-0
- Drug.DrugBank
- DB00059
- Drug.ChemSpiderID
- none
- Drug.UNII
- 7D96IR0PPM
via Wikipedia infobox
Research
547 papers- Pegaspargase.2006
- Pegaspargase in Practice: Minimizing Toxicity, Maximizing Benefit.Current hematologic malignancy reports · 2021
- Pegaspargase: A Review in Acute Lymphoblastic Leukaemia.Drugs · 2019
- Pegaspargase-induced hypertriglyceridemia in a patient with acute lymphoblastic leukemia.Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners · 2020
- Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial.Blood advances · 2023
via PubMed
Wikidata facts
Show 1 more fact
- World Health Organisation international non-proprietary name
- pegaspargase
Sources (2)
via Wikidata · CC0
~1 min read
Article
1 sectionsContents
- References
Pegaspargase, sold under the brand name Oncaspar, is a medication used in the treatment of acute lymphoblastic leukemia (ALL). Often it is used together with anthracycline, vincristine, and corticosteroids (for example prednisone and dexamethasone). Pegaspargase can be administered either via an intravenous infusion or a intramuscular injection.
Known side effects include allergic reactions, coagulopathy, high blood sugar, affecting liver function, pancreas inflammation, and blood clots in the brain. There is no data regarding the usage of pegaspargase during pregnancy. Therefore, caution should be observed and pegaspargase should only be used during pregnancy when the benefits outweigh the possible risks.
Available in 16 languages
- Español
- Français
- Deutsch
- 中文
- 日本語
- العربية
- Bahasa Indonesia
- Odia
- Polski
- Romanian
- Serbian
- Serbian (Latin)
- Svenska
- Tiếng Việt
- Ukrainian
via Wikidata sitelinks · CC0